Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2024-09-30 Regulatory Filings
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
[기재정정]유형자산취득결정
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Ilseong IS) regarding an amendment to a previous disclosure about the acquisition of tangible assets (real estate). It details the change in the expected completion date of the acquisition. Since this is a specific regulatory disclosure regarding corporate asset acquisition and does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2024-09-30 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Il Sung IS Co., Ltd. (formerly Il Sung Pharmaceuticals) for the period ending June 30, 2024. It contains comprehensive financial information, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-13 Korean
[기재정정]유형자산취득결정
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Ilseong IS) regarding an amendment to a previous disclosure about the acquisition of tangible assets (real estate). It details the change in the expected completion date of construction. Since this is a specific regulatory disclosure regarding corporate asset acquisition and does not fit into the other specialized categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2024-06-27 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the 1st quarter of 2024 (제 65 기 1분기) for Ilsung IS Co., Ltd. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, dividend resolutions, election of directors, and other agenda items. This fits the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2024-03-22 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). It details the change in board composition, including the name, background, and term of the newly appointed director. This falls under the category of board or management changes.
2024-03-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.